WEE1 and sarcoma: Since WEE1 inhibition with adavosertib induces premature mitotic entry and DNA damage (40, 41) in other cancer types, we next determined the effect of adavosertib on cell cycle progression in our patient-derived CIC-DUX4 sarcoma cells.